David McIntosh: UK Plasma Action – a Founder’s Reflections
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
”UK Plasma Action – a Founder’s Reflections
The UKPA campaign, launched in June 2019, was aimed at the discontinuation of a 23 year-old ban on the pharmaceutical use of UK donors’ plasma.
Much has happened since then and much good work has been done. Our donations are once again contributing to the manufacture of some vital plasma-derived medicines. The worst of the waste has been halted.
However, it seems appropriate, seven years on, to pause and reflect on the progress made so far – and the extent to which more action is still required.
The 20th Century fears about alleged risks of Variant Creutzfeldt Jakob disease in this context have now finally been dispelled.
However, the full Regulatory consequences and Healthcare gains from this welcome development are yet to be realised.
There is unfinished business here…….”
Other posts featuring David McIntosh on Hemostasis Today.
-
Aug 9, 2026, 02:26Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
-
Aug 9, 2026, 02:08Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
-
Aug 9, 2026, 01:48Paolo Zamboni: Treating Post-Thrombotic Syndrome by Eliminating Venous Reflux
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care
-
Aug 8, 2026, 20:33Delilah F.: March Is Blood Clot Awareness Month
-
Aug 8, 2026, 20:31Jackie Maybin: Top 10 Research Priorities for Problematic Menstrual Bleeding in the UK
-
Aug 8, 2026, 17:02Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka